发明授权
- 专利标题： Substituted imidazole compounds as KSP inhibitors
- 专利标题（中）： 取代的咪唑化合物作为KSP抑制剂
-
申请号： US11502303申请日： 2006-08-09
-
公开(公告)号： US07626040B2公开(公告)日： 2009-12-01
- 发明人: Paul A. Barsanti , Yi Xia , Weibo Wang , Kris G. Mendenhall , Liana M. Lagniton , Savithri Ramurthy , Megan C. Phillips , Sharadha Subramanian , Rustum Boyce , Nathan M. Brammeier , Ryan Constantine , David Duhl , Annette O. Walter , Tinya J. Abrams , Paul A. Renhowe
- 申请人： Paul A. Barsanti , Yi Xia , Weibo Wang , Kris G. Mendenhall , Liana M. Lagniton , Savithri Ramurthy , Megan C. Phillips , Sharadha Subramanian , Rustum Boyce , Nathan M. Brammeier , Ryan Constantine , David Duhl , Annette O. Walter , Tinya J. Abrams , Paul A. Renhowe
- 申请人地址： US CA Emeryville
- 专利权人： Novartis Vaccines and Diagnostics, Inc.
- 当前专利权人： Novartis Vaccines and Diagnostics, Inc.
- 当前专利权人地址： US CA Emeryville
- 代理商 Vinit Kathardekar; Lorna Tanner
- 主分类号： C07D233/64
- IPC分类号： C07D233/64 ; C07D401/12 ; C07D279/12 ; C07D413/12 ; C07D403/12
摘要：
The present invention relates to new substituted imidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the derivatives together with pharmaceutically acceptable carriers, and uses of the compounds. The compounds of the invention have the following general formula:
公开/授权文献
- US20070037853A1 Substituted imidazole compounds as KSP inhibitors 公开/授权日：2007-02-15